tirzepatide liver enzymes Eli Lilly's Zepbound improved scarring in mid-stage MASH study Drug-induced liver injury secondary to

Addressing Stubborn Fat After Weight Loss Even after weight reduction, some individuals may continue to experience localised areas of stubborn fat that are resistant to diet and exercise alone

Animal studies showed potential harm to developing fetuses, and theres not enough human data to know if theyre safe during pregnancy

Doctors swear an oath to first, do no harm, and are expected to use treatments supported by evidence or, at minimum, a plausible expectation of benefit outweighing risks

TWO-HORSE RACE The injectable weight-loss drug market is dominated by Novo Nordisk, which manufactures Ozempic and Wegovy - and its rival Eli Lily, whose best-sellers are Zepbound and Mounjaro